• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

drug development

	Next higher product group	drug discovery

Record changed: 2022-04-17

Advertisement

More documents for drug development

• [1] Hovione. (5/9/22). "Press Release: Hovione and Jixing Announce an Exclusive Global License Agreement for Ophthalmology Program". Lisbon & Shanghai....
• [2] ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC....
• [3] Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel....
• [4] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
• [5] MorphoSys AG. (3/10/22). "Press Release (Ad hoc): MorphoSys AG Reports Non-cash Impairment Charge of approx. € 231 Million on Goodwill after Consolidation of Research and Discovery Functions, Corresponding Increase of Group Operating Expenses in 2021". P...
• [6] AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA....
• [7] Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel....
• [8] Merck KGaA. (1/13/22). "Press Release: Merck Announces New Appointments in Global R&D and Strategy Leadership for Healthcare Business Sector". Darmstadt....
• [9] Novartis AG. (1/6/22). "Press Release: Novartis Announces Collaboration with Alnylam to Explore Targeted Therapy to Restore Liver Function". Basel....
• [10] Novartis AG. (12/20/21). "Press Release: Novartis Strengthens Immunotherapy Pipeline with Option, Collaboration and License Agreement with BeiGene for TIGIT inhibitor Ociperlimab". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.